bioRxiv Science⌕ Search

Biology subjects

La, V.

Publications and source records attributed to La, V..

3 recordsLinked to original sources

Rotational settings quantize nucleosome movement by chromatin regulators

Proper nucleosome positioning is essential for gene regulation and genomic integrity. Regulated nucleosome assembly and positioning results from a need to protect DNA sequences genome-wide, constrained by the known intrinsic sequence preferences of histones. Current models posit that chromatin regulators override the intrinsic preferences to establish the nucleosome landscapes observed in vivo, implying minimal roles for DNA sequence in guiding nucleosomal structure in cells. In contrast, we demonstrate that DNA sequence intrinsically guides the structure and remodeling of nucleosomes from yeast to mammals. We demonstrate that nucleosomes with weak translational settings in vitro, in yeast, and in mammalian cells demonstrate a clear preference for inward-facing A/T dinucleotides and outward facing G/C dinucleotides, at 10 bp spacings consistent with established preferences for rotationally positioned nucleosomes. Foreign DNA sequences heterologously inserted into the yeast genome obey similar rules, indicating that DNA sequence itself is causal. Finally, remodelers and transcription elongation change the preference among the alternative translational positions 10 bp apart, retaining the rotational setting. From these results, we propose that DNA sequence creates an energy landscape with preferred rotational settings every [~]10 bp, and that chromatin regulators, rather than overriding these preferences, navigate within them. This "detent" mechanism provides a unifying framework for understanding how diverse cellular processes achieve precise nucleosome positioning while maintaining the same DNA face exposed to regulatory factors.

molecular biology↗

Multiomics characterization of cell type repertoires for urine liquid biopsies

Urine is assayed alongside blood in medicine, yet current clinical diagnostic tests utilize only a small fraction of its total biomolecular repertoire, potentially foregoing high-resolution insights into human health and disease. In this work, we characterized the joint landscapes of transcriptomic and metabolomic signals in human urine. We also compared the urine transcriptome to plasma cell-free RNA, identifying a distinct cell type repertoire and enrichment for metabolic signal. Untargeted metabolomic measurements identified a complementary set of pathways to the transcriptomic analysis. Our findings suggest that urine is a promising biofluid yielding prognostic and detailed insights for hard-to-biopsy tissues with low representation in the blood, offering promise for a new generation of liquid biopsies.

genomics↗

Pharmacokinetics of Extended-release Buprenorphine (Ethiqa) in Female Yorkshire Swine (Sus scrofa domestica)

Despite the use of swine as a large animal translational surgical model, precise dosing regimens for commonly used analgesics such as buprenorphine, are currently lacking in this species. A newly available extended-release formulation of buprenorphine (XRB, Ethiqa) is FDA-indexed and approved for use in mice and rats; however, no studies have examined the efficacy and pharmacokinetic parameters of XRB in swine. The goal of this study was to determine the pharmacokinetics of the newly available XRB in swine. We hypothesized that after a single subcutaneous administration of XRB in adult swine, buprenorphine plasma concentrations would be at or above the therapeutic threshold of 0.1 ng/mL and that local injection side effects would be minimal. XRB was administered once, subcutaneously to two separate cohorts of adult female Yorkshire swine at low and high doses (0.2 and 0.4 mg/kg, respectively; n = 3 and 2). Blood was collected from an indwelling jugular catheter prior to and after XRB administration (13 total time points). Individual animal data indicated all animals reached therapeutic buprenorphine plasma concentrations by 8 h post administration. Average plasma buprenorphine levels for both the low- and high-dose cohorts reached therapeutic concentrations starting at 1.5 h after XRB administration and were maintained above therapeutic concentrations throughout the 96-h study period. In the low-dose cohort, the average half-life was 212.6 {+/-} 107.1 h, whereas the half-lives in the high-dose cohort was 63.8 and 48.9 h. As expected, histology of XRB subcutaneous sites revealed mild injection site reactions characterized by granulomatous inflammation with intralesional cholesterol cleft formation. These results support our hypothesis and indicate that all animals maintained therapeutic plasma buprenorphine levels beginning at 8 h and maintaining past 96 h. Thus, XRB at either dose provide therapeutic levels of plasma buprenorphine and therefore its use should be further explored in swine.

pharmacology and toxicology↗